Imatinib mesylate induced erythroderma: A rare case report

Journal Title: IP Indian Journal of Clinical and Experimental Dermatology - Year 2017, Vol 3, Issue 2

Abstract

Imatinib, a specific tyrosine kinase inhibitor is a newer anticancer agent, which has shown excellent efficacy in managing chronic myeloid leukemia. It is generally well tolerated with few side effects. Most commonly reported adverse events are maculopapular eruptions and periorbital edema. Severe adverse reactions are seen in 5% of patients. Exfoliative dermatitis has been very rarely reported with this drug. We report a case of a 55-year-old female who initially presented with a maculopapular rash and developed erythroderma on continuation of the drug.

Authors and Affiliations

Snehal Balvant Lunge, Rohan Bhise

Keywords

Related Articles

Nails- a window to internal organs: a cross sectional study of nail changes in systemic diseases in a tertiary care hospital

Background: Many systemic disorders leave their mark on the nails and, therefore, provide physicians with valuable clues to diagnosis. In spite of this knowledge, there has been relatively little attention paid to the na...

Electromyography and its role in dentistry

Electromyography (EMG) is the subject which deals with detection, analysis and utilization of electrical signals emanating from skeletal muscles.(1) The electric signal produced during muscle activation, known as the myo...

Comparison between beta hydroxy acid chemical peel and intense pulsed light in the treatment of facial acne vulgaris in Asian patients

Background: Although acne is not physically disabling, there is significant demand for effective acne therapies. Chemical peeling is the most widely used procedure in the management of acne and acne scars, but there are...

Clinical and Histopathological Study of 50 Cases of Lichen Planus

Abstract Background: Lichen Planus (LP) is a unique, common inflammatory disorder that affects the skin, mucous membrane, nail and hair. Though lichen planus has distinct colour, morphology and distribution it can presen...

A study of cutaneous manifestations of chronic pulmonary diseases among patients attending a tertiary care hospital

Abstract Background: Cutaneous manifestations are frequently associated with pulmonary diseases and vice versa. Aim: To study the frequency of cutaneous manifestations of pulmonary disease in patients attending our hospi...

Download PDF file
  • EP ID EP300066
  • DOI 10.18231/2455-6769.2017.0022
  • Views 111
  • Downloads 0

How To Cite

Snehal Balvant Lunge, Rohan Bhise (2017). Imatinib mesylate induced erythroderma: A rare case report. IP Indian Journal of Clinical and Experimental Dermatology, 3(2), 88-90. https://europub.co.uk/articles/-A-300066